NeurogesX Axes 57 Pct. of Jobs as FDA Rejects Patch - Mar. 8, 2012

Having trouble viewing this email? View in Browser.

Thursday, March 08, 2012  |   |   |   |  Crown Bioscience Inc. leads the field in providing unique translational platforms and cost effective drug discovery solutions for its biotech and pharmaceutical partners in dedicated therapeutic areas: Oncology and Metabolic Disease. Our multi-disciplinary team of experts, headquartered in the heart of Silicon Valley, with wholly own research facilities in Kanapolis, Beijing (China), and Taicang (China)., provides an integrated service solution from your idea to an enabling IND, including: preclinical, translational and clinical capabilities. CrownBio offers a truly integrated approach to undertaking complete drug discovery programs as well as hit identification, hit-to-lead, and lead optimization projects. To learn more about our unique portfolio and breadth of services, visit www.crownbio.com or call us at 603-686-9330.   •  NeurogesX, Inc. (NGSX) Axes 57% of Staff as FDA Rejects Patch More... •  Gilead Sciences, Inc. (GILD)'s Four-in-One AIDS Pill is Effective in Study More... •  Johnson & Johnson (JNJ)'s Zytiga Scores Big Win, Hurts Dendreon Corporation (DNDN), Helps Medivation, Inc. (MDVN) More... •  Novartis AG (NVS), Bayer AG (BAY.F) Vying for Pfizer Inc. (PFE)'s Animal Health Business More... •  Promedior Scores $21.5 Million for Fibrotic Diseases More... •  Bellicum Pharmaceuticals, Inc. Closes $20 Million Series B Financing More... •  Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Hid Actos Adverse Effects From Regulators, Suit Says More... •  Daiichi Sankyo, Inc. (D4S.F) Announces Organizational Restructuring as of April 1, 2012 More... More Top News PPD Central Labs One comprehensive solution for all stages of the product lifecycle. Combine the expertise of a leading contract research organization (CRO) with global central laboratories that are among the world's largest dedicated exclusively to clinical trials. We offer: • Comprehensive range of central lab services • Extensive reach • High level of accuracy Please click here for more information. •  "Macho" Gene That Makes Men Behave Aggressively Has Been Found, Prince Henry's Institute of Medical Research Study More... •  Radiation Blast May Turbocharge Bristol-Myers Squibb Company (BMY) Melanoma Drug, Memorial Sloan-Kettering Cancer Center Report Shows More... •  Sperm Can Do Calculus! Max Planck Institute Study More... •  Thousands More Should be on Dementia Drug Aricept, The New England Journal of Medicine Reveals More... •  New Alzheimer's Marker Strongly Predicts Mental Decline, Washington University in St. Louis Study More... •  Tonsils Make T-Cells, Too, Ohio State University Study More... •  Cancer Scans May Give False Picture of Genes Driving Disease, London Research Institute Study More... •  Strong Scientific Evidence That Eating Berries Benefits the Brain, American Chemical Society Study More...   More Featured News SafeBridge Consultants, Inc. announces two Potent Compound Safety Training offerings (may be taken separately or consecutively) The SafeBridge original Potent Compound Safety "Boot Camp"® (Boot Camp I) is a comprehensive two-day course in pharmaceutical potent compound safety focused on training EH&S and related professionals in critical technical concepts and proactive safety programs in pharmaceutical industrial hygiene, occupational and environmental toxicology, analytical chemistry, and risk communication. The SafeBridge Advanced Concepts to Support Drug Development of Potent Compounds from R&D through Manufacturing (Boot Camp II) is a one-day advanced course focused on case studies and problem-solving to address potent compound safety issues in discovery, development, contract manufacturing and commercialization. COURSE SEATING IS LIMITED AND USUALLY SELLS OUT! San Diego, CA Boot Camp I May 15-16, 2012 Boot Camp II May 17, 2012 Contact: Susan Custer: susan.custer@safebridge.com or 650-961-4820 x 231 or WorldPharmaCongress.com. The CMO Market Outlook to 2017 • Develop contract manufacturing strategies based on regional forecast performance and key industry trends. • Analyze the strengths and weaknesses of global players in the CMO market. • Evaluate the future outlook of clinical quantity manufacturing as against finished dose supply. Click Here for More Information. Building Novel Applications with Pipeline Pilot to Drive Next Generation Sequencing This case study shows how scientists are streamlining the process of analyses of DNA sequence information. Enabled by new DNA sequencing technologies, many more scientists and informaticians are interrogating larger and more complex data set. Request Now! • BioMidwest (Chicago, Illinois) Takeda Pharmaceuticals Senior Medical Director Pharmacovigilance Oversee the work of the Clinical Safety physicians who support each therapeutic area. This position will liaise with other TGRD departments (Clinical Research, Regulatory, Pharmaco-epidemiology) to ensure comprehensive product stewardship for developmental products. • Pharm Country (Lebanon, New Hampshire) Adimab LLC Scientist in Cell Culture Development Responsible for generating stable mammalian cell lines, selecting highly productive clones, and developing and optimizing in-house fermentation processes for rapid production of IgG antibodies at multi-liter scale. • Pharm Country (Lebanon, New Hampshire) Adimab LLC Scientist in Membrane Protein Biochemistry Will carry out purification, characterization, and formulation of integral membrane proteins and conduct antibody discovery and optimization research. • Pharm Country (Paramus, New Jersey) Mannkind Corporation Associate Director, Scientific Communications Responsible for writing MannKind documents; managing writing projects and timelines; managing and mentoring medical writing staff and external business consultants with a variety of writing responsibilities to achieve Mannkind's objectives and goals. • Biotech Bay (Novato, California) BioMarin Pharmaceutical Inc. Associate Medical Director, Clinical Science Will report to the Vice President of Clinical Science, needs to be proficient in clinical study, program design and execution. Experience and knowledge in interaction with clinical investigators, collaboration with regulatory affairs, and FDA interactions is required. Get Noticed! Add your resume to the BioSpace Career Center! See more than 5,000 job postings in the BioSpace Career Center! Pharm Country Career Fair Job seekers can spend a day with HR representatives and Hiring Managers from top biotech, pharma, medical device and diagnostics companies in the tri-state area. Candidates with a 4-year degree in the life sciences and a minimum of 2-years of industry related experience are invited to attend. (Equivalent work experience may be considered in lieu of a four-year college degree. PhD and Postdoc candidates welcome.) Exhibiting companies are recruiting for positions in areas such as: QA/QC, clinical research, engineering, manufacturing, biostatistics, clinical data management, chemistry, regulatory affairs, and research. Job seekers may register here. • Pharm Country Career Fair, Bridgewater, NJ March 22, 2012 • Biotech Beach Career Fair, La Jolla, CA April 17, 2012 • BioCapital Career Fair, Bethesda, MD April 25, 2012 • Pharm Country Career Fair, King Of Prussia, PA May 1, 2012 • BioNC Career Fair, Durham, NC May 2, 2012 • Biotech Bay Career Fair, Burlingame, CA May 29, 2012 More information about BioSpace's Career Fairs BioSpace White Paper Biotech Career Fairs For Job Seekers 101: Control Your Experience By June Salvati, BioSpace Director of Events and Corporate Services ViroPharma Incorporated 730 Stockton Drive Exton, Pennsylvania 19341 U.S.A. Phone: 610-458-7300 Fax: 610-458-7380 ViroPharma Incorporated is a biotechnology pharmaceutical company dedicated to developing and commercializing products that help address dangerous, potentially life-threatening conditions such as cytomegalovirus, hereditary angioedema (HAE), and C. difficile. ViroPharma is headquartered in Exton, PA and has operations in Europe. More Company Profiles FREE Subscription to PharmaVOICE PharmaVOICE delivers the views, opinions, and insights of executives who are shaping the direction of the dynamic life-sciences industry. Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship BioSpace Inc. 6465 South Greenwood Plaza, Suite 400 Centennial, Colorado 80111 U.S.A. Phone: 877-277-7585 Fax: 800-595-2929 BioSpace Inc. 90 New Montgomery Street, Suite 414 San Francisco, California 94105 U.S.A. Phone: 877-277-7585 Fax: 415-576-9217 Send questions and comments to the BioSpace News Beat Team. Editor & Publisher: Rosemary Do Editorial & Production Staff: Lana Ho, Maysa Darwish, Tammy Liu, Michelle Wong BioSpace.com - Life. Science. Community. • BioSpace is a registered trademark of BioSpace, Inc. • Please distribute this e-cast freely. • Credit any excerpts as follows: Copyright 2012 BioSpace http://www.biospace.com • While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes. If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply Subscribe here. Safely unsubscribe from Biospace.com e-mail at any time by managing your account here.